Financial Ratios

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1347.65-28.4 (-2.06 %)
PREV CLOSE ( ) 1376.05
OPEN PRICE ( ) 1381.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 46933
TODAY'S LOW / HIGH ( )1343.00 1383.65
52 WK LOW / HIGH ( )891.3 1519
NSE1347.30-27.9 (-2.03 %)
PREV CLOSE( ) 1375.20
OPEN PRICE ( ) 1376.00
BID PRICE (QTY) 1347.30 (1027)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2974196
TODAY'S LOW / HIGH( ) 1342.40 1383.65
52 WK LOW / HIGH ( )896.3 1519
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)30.6035.7325.3528.7523.44
   CEPS(Rs)37.9842.5031.1636.1930.51
   DPS(Rs)8.505.005.004.003.00
   Book NAV/Share(Rs)304.76278.59246.66215.43195.35
   Tax Rate(%)28.2224.2326.5621.8024.25
Margin Ratios
   Core EBITDA Margin(%)22.9322.7725.2119.8219.18
   EBIT Margin(%)21.0123.5123.2522.1319.24
   Pre Tax Margin(%)20.8523.3422.8821.8719.11
   PAT Margin (%)14.9617.6916.8017.1014.48
   Cash Profit Margin (%)18.5721.0420.6621.5318.85
Performance Ratios
   ROA(%)9.3111.919.4311.9410.65
   ROE(%)10.4913.6110.9714.0012.67
   ROCE(%)14.7118.0515.1518.0816.69
   Asset Turnover(x)0.620.670.560.700.74
   Sales/Fixed Asset(x)2.192.291.812.152.20
   Working Capital/Sales(x)1.551.871.622.121.83
Efficiency Ratios
   Fixed Capital/Sales(x)0.460.440.550.470.45
   Receivable days62.8465.2898.9390.5977.02
   Inventory Days74.7973.5991.6079.3082.64
   Payable days132.39117.14184.38169.73156.18
Valuation Parameters
   PER(x)29.4428.5132.1614.7122.58
   PCE(x)23.7123.9626.1611.6917.35
   Price/Book(x)2.963.663.311.962.71
   Yield(%)0.940.490.610.950.57
   EV/Net Sales(x)4.545.255.742.653.43
   EV/Core EBITDA(x)16.8818.4419.679.3313.79
   EV/EBIT(x)20.6921.0722.9311.1916.92
   EV/CE(x)2.603.172.821.652.31
   M Cap / Sales4.605.345.822.693.45
Growth Ratio
   Net Sales Growth(%)2.6636.08-10.722.308.64
   Core EBITDA Growth(%)-2.9432.76-8.4016.9121.70
   EBIT Growth(%)-9.4935.43-5.7119.5530.49
   PAT Growth(%)-14.3340.98-11.8022.7628.59
   EPS Growth(%)-14.3740.92-11.8222.6728.50
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)4.954.313.793.454.00
   Quick Ratio(x)3.742.982.642.292.79
   Interest Cover(x)128.33142.2762.7783.23147.90
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.